Qilian International Holding Group Limited (NASDAQ:QLI) Short Interest Up 61.6% in June

Qilian International Holding Group Limited (NASDAQ:QLI) saw a significant growth in short interest in June. As of June 30th, there was short interest totalling 13,900 shares, a growth of 61.6% from the June 15th total of 8,600 shares. Based on an average daily volume of 30,200 shares, the short-interest ratio is currently 0.5 days. Approximately 0.9% of the company’s stock are short sold.

Qilian International Holding Group Trading Up 29.5 %

Shares of NASDAQ QLI traded up $1.26 during mid-day trading on Friday, reaching $5.53. The company had a trading volume of 86,226 shares, compared to its average volume of 26,230. Qilian International Holding Group has a twelve month low of $1.78 and a twelve month high of $5.97. The stock’s 50 day moving average is $3.78 and its 200-day moving average is $3.32.

Qilian International Holding Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.